| Title | Organization | LOI date | Due Date | Keywords | FOA |
|---|---|---|---|---|---|
| Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical Trial Optional) | National Institutes of Health | 10/3/2023 | 11/3/2023 | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures | RFA-AG-24-025 |
| Building Evidence for Effective Strategies to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups | Leukemia & Lymphoma Society (LLS) | 9/15/2023 | 1/26/2024 | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Clinical Trials | |
| Understanding How Health Insurance Affects Equity in Access to Care for Patients with and Survivors of Blood Cancer | Leukemia & Lymphoma Society (LLS) | 9/15/2023 | 1/26/2024 | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Health Insurance | |
| Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) | National Cancer Institute | 9/13/2023 | 10/13/2023 | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures | RFA-CA-24-005 |
| NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed) | National Institutes of Health | 9/6/2023 | 10/6/2023 | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures | PAR-23-229 |
| Arnold O. Beckman Postdoctoral Fellowship | Arnold and Mabel Beckman Foundation | 9/6/2023 | 12/12/2023 | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures | |
| IASLC Young Investigator Grant | International Lung Cancer Foundation | Young Investigator, Health Equity Research, Antibody Drug Conjugates, Precision Medicine | |||
| IASLC Young Investigator Grants | Lung Cancer Foundation of America | Young Investigator, Health Equity Research, Antibody Drug Conjugates, Precision Medicine | |||
| Addressing Systemic Drivers of Racial Health Inequities | Pfizer | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures | |||
| AGA-Caroline Craig Augustyn & Damian Augustyn Award in Digestive Cancer | American Gastroenterological Association | Health Equity Research, Cancer Prevention, Clinical Research, Cancer Control | |||
| AGA-Caroline Craig Augustyn and Damian Augustyn Award in Digestive Cancer | American Gastroenterological Association (AGA) Research Foundation | Health Equity Research, Cancer Prevention, Clinical Research, Cancer Control | |||
| R. Robert & Sally Funderburg Research Award in Gastric Cancer | American Gastroenterological Association (AGA) Research Foundation | Health Equity Research, Cancer Prevention, Clinical Research, Cancer Control | |||
| Robert & Sally Funderburg Research Award in Gastric Cancer | American Gastroenterological Association | Health Equity Research, Cancer Prevention, Clinical Research, Cancer Control | |||
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) | National Institutes of Health | 10/5/2023 | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures | PAR-21-166 | |
| ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant | LUNGevity Foundation | 10/5/2023 | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures | ||
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) | National Institutes of Health | 10/16/2023 | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures | PAR-22-091 | |
| ASTRO-MRA Young Investigator Award in Radiation Oncology | Melanoma Research Alliance | 10/20/2023 | Young Investigator, Health Equity Research, Antibody Drug Conjugates, Precision Medicine | ||
| Bristol Myers Squibb-MRA Young Investigator Awards in Immunotherapy | Melanoma Research Alliance | 10/20/2023 | Young Investigator, Health Equity Research, Antibody Drug Conjugates, Precision Medicine | ||
| Dermatology Career Development Award | Melanoma Research Alliance | 10/20/2023 | Young Investigator, Health Equity Research, Antibody Drug Conjugates, Precision Medicine | ||
| Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) | National Institutes of Health | 11/3/2023 | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures | PAR-23-246 | |
| NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) | National Institutes of Health | 11/12/2023 | Diversity, Research Scientist Development, Clinical Trial | PAR-21-296 | |
| Cellular and Biochemical Engineering | National Science Foundation | 12/31/2023 | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures, limited | ||
| NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) | National Cancer Institute | 2/6/2024 | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Cancer Moonshot | RFA-CA-050 | |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) | National Institutes of Health | 2/16/2024 | Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures | PAR-23-255 | |
| Postdoctoral Fellowship to Promote Racial Diversity | Cancer Research Institute | 9/1/2023 | Early-stage, diversity | ||
| Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed) | National Cancer Institute | 12/15/2023 | Disparities, biology, Diversity, underrepresented, cancer initiation, progression, exploratory | ||
| Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed) | National Cancer Institute | 12/15/2023 | Disparities, biology, Diversity, underrepresented, cancer initiation, progression, | ||
| Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) | National Institutes of Health | 11/17/2023 | Exploratory, Diversity, clinical, early-stage | ||
| Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) | National Institutes of Health | 12/8/2023 | Early-stage, predoctoral, training, clinical, fellowship, physician, Diversity, | ||
| NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) | National Institutes of Health | 2/12/2024 | Diversity, Research Scientist Development, Clinical Trial | ||
| NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) | National Institutes of Health | 2/12/2024 | Diversity, Research Scientist Development, Clinical Trial | ||
| NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) | National Institutes of Health | 2/12/2024 | Diversity, Early-stage, training, career transition, postdoctoral, biomedical, | ||
| NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) | National Institutes of Health | 2/12/2024 | Clinical Trials, Diversity, Early-stage, Career Transition, postdoctoral | ||
| The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) | National Institutes of Health | 10/5/2023 | Innovation, population research, occupation, work-place, disparities, diversity, social | ||
| Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional) | National Institutes of Health | 10/5/2023 | Innovation, patient-clinician, communication, disparities, diversity, outcomes, equity | ||
| Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) | National Institutes of Health | 2/28/2024 | epidemiology, diversity, risks, rural, poverty, population-based research, cohort | ||
| Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) | National Institutes of Health | 2/5/2024 | Survivor, treatment, diversity, observational | ||
| ASPIRE: A Supplement to Promote Inclusion for Research Excellence | Susan G. Komen for the Cure | 11/1/2023 | Diversity, breast cancer, outcomes, equity, training, early-stage |
